Our Research
The goal of our research is to establish scientific principles and methods in drug evaluation with societal perspectives in mind.
Pharmaceutical research and development (R&D), clinical development in particular, regulatory review and approval of new drugs,
and post marketing activities are our research interests.
We provide evidence on R&D efficiency, performance and outcomes of regulations, and public health impact through rigorous analysis based on economic models. Conflicts in global pharmaceutical R&D, including recent launch delay of new drugs in Japan and so-called ethnic differences, are always high on our agenda.
The outputs of our research are not only presented in academic gatherings and published as journal articles, but also used in professional meetings, policy debates, and in discussions on drug policy within political parties.
Our major research topics are as follows:
We provide evidence on R&D efficiency, performance and outcomes of regulations, and public health impact through rigorous analysis based on economic models. Conflicts in global pharmaceutical R&D, including recent launch delay of new drugs in Japan and so-called ethnic differences, are always high on our agenda.
The outputs of our research are not only presented in academic gatherings and published as journal articles, but also used in professional meetings, policy debates, and in discussions on drug policy within political parties.
Our major research topics are as follows:
(1) Economic and regulatory impact on global pharmaceutical R&D activities
(2) Regulatory review and approval of new drugs
(3) Roles of 'ethnic differences' in decisions of drug development
(4) Drug safety and regulatory environments
(5) Prediction and assessment of pharmacokinetics in R&D
Contact Us
TELF03-5800-6988
FAXF03-5800-6949
PRS Secretary
